Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbiome Transplantation in Cirrhosis
NCT06533852Phase 3Recruiting
- Sponsor
- CiberMed
- Start
- Jul 2025
- Primary completion
- Jan 2029
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of fecal microbiome transplant in decompensated cirrhosis, sponsored by CiberMed. Started Jul 2025; status: recruiting.
02
Drugs
fecal microbiome transplant
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on NCT06533852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06533852.